Page last updated: 2024-10-24

regulation of ATP biosynthetic process

Definition

Target type: biologicalprocess

Any process that modulates the frequency, rate or extent of ATP biosynthetic process. [GOC:obol]

Regulation of ATP biosynthetic process is a complex and tightly controlled process that ensures the cell has a constant supply of ATP, the primary energy currency of life. This process involves multiple levels of regulation, including:

1. **Substrate availability:** ATP synthesis requires the availability of ADP, phosphate, and a source of electrons. The levels of these substrates are constantly monitored and adjusted to meet the cell's energy demands.

2. **Enzyme activity:** The enzymes involved in ATP synthesis, such as ATP synthase, are subject to both allosteric regulation and covalent modification. For instance, ATP synthase is regulated by the proton gradient across the mitochondrial membrane, ensuring that ATP production is coupled to electron transport.

3. **Gene expression:** The expression of genes encoding enzymes involved in ATP synthesis is also regulated. This regulation is often responsive to changes in energy demand, nutrient availability, and environmental conditions.

4. **Metabolic feedback loops:** ATP itself acts as a feedback inhibitor of many metabolic pathways that produce ATP, ensuring that ATP production is balanced with the cell's energy needs.

5. **Cellular signaling pathways:** Various signaling pathways, such as the AMPK pathway and the insulin signaling pathway, influence ATP production by modulating the activity of key enzymes and the expression of genes involved in ATP metabolism.

6. **Organellar communication:** Mitochondria, the primary site of ATP production, communicate with other cellular compartments, such as the nucleus and the cytoplasm, to coordinate ATP production with cellular needs.

These intricate regulatory mechanisms work in concert to ensure the cell has an adequate supply of ATP to meet its energy requirements. Dysregulation of ATP biosynthesis can lead to various cellular malfunctions and diseases.'
"

Proteins (1)

ProteinDefinitionTaxonomy
Sphingosine kinase 2A sphingosine kinase 2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9NRA0]Homo sapiens (human)

Compounds (9)

CompoundDefinitionClassesRoles
fingolimod hydrochloridefingolimod hydrochloride : The hydrochloride salt of 2-amino-2-[2-(4-octylphenyl) ethyl]-1,3-propanediol (fingolimod).

Fingolimod Hydrochloride: A sphingosine-derivative and IMMUNOSUPPRESSIVE AGENT that blocks the migration and homing of LYMPHOCYTES to the CENTRAL NERVOUS SYSTEM through its action on SPHINGOSINE 1-PHOSPHATE RECEPTORS. It is used in the treatment of MULTIPLE SCLEROSIS.
hydrochlorideimmunosuppressive agent;
prodrug;
sphingosine-1-phosphate receptor agonist
4-(4-(4-chloro-phenyl)thiazol-2-ylamino)phenolsubstituted aniline
sphingosine2-aminooctadec-4-ene-1,3-diol : A 2-aminooctadecene-1,3-diol having its double bond at position 4.

sphing-4-enine : A sphingenine in which the C=C double bond is located at the 4-position.

sphingenine : A 2-aminooctadecene-1,3-diol having (2S,3R)-configuration.

sphingoid : Sphinganine, its homologs and stereoisomers, and the hydroxy and unsaturated derivatives of these compounds.
sphing-4-eninehuman metabolite;
mouse metabolite
n,n-dimethylsphingenineN,N-dimethylsphingosine : A sphingoid that is sphingosine in which the two amino hydrogens are replaced by methyl groups.

N,N-dimethylsphingosine: a sphingosine kinase inhibitor
aminodiol;
sphingoid;
tertiary amino compound
EC 2.7.1.91 (sphingosine kinase) inhibitor;
metabolite
es-2851-deoxysphinganine : A bioactive sphingoid, sphinganine, in which the terminal hydroxy group has been replaced by a hydrogen.

spisulosine: from marine organism, Spisula polynyma; structure in first source
amino alcohol;
sphingoid
antineoplastic agent
3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amideorganochlorine compound
bml 258
pf-543PF-543: Sphingosine Kinase 1 Selective Inhibitor; structure in first sourcesulfonamide
rome(2R)-2-amino-2-(methoxymethyl)-4-(4-octylphenyl)butan-1-ol : A 2-amino-2-(methoxymethyl)-4-(4-octylphenyl)butan-1-ol that has R-configuration. It is a sphingosine kinase-2 inhibitor.

Rome: The capital city of Italy.
2-amino-2-(methoxymethyl)-4-(4-octylphenyl)butan-1-olEC 2.7.1.91 (sphingosine kinase) inhibitor